BERKELEY, Calif. and MAINZ, Germany - Mainz Biomed NV (NASDAQ:MYNZ), a company focused on early cancer detection diagnostics, has announced its return to compliance with Nasdaq's stockholders' equity ...

After an underwhelming 2023/24 season, Mainz are now in the running for the UEFA Champions League places. So what's clicking ...

Luton’s on-loan midfielder Tom Krauß has been linked with a move back to Germany during the transfer window.

MAINZ, Germany — German-born U.S. midfielder Lennard Maloney has joined Mainz from Bundesliga rival Heidenheim, where he was ...

Musk's support for AfD has helped what was once a fringe political party enter the mainstream, lifting it up in front of a ...

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements ...

Sky Germany reports that Mainz are now leading the race ahead of Borussia Mönchengladbach for Montpellier forward Arnaud ...

Steffen Baumgart has overseen his first win as Union Berlin coach as his team ended its 11-game winless run with a 2-1 ...

Mainz are closing in on signing Montpellier winger Arnaud Nordin (26), reports Le Parisien. An agreement is reportedly close ...

Manchester City could yet lose midfield talent James McAtee on loan for the remainder of the season amid growing interest ...

Please visit Mainz Biomed’s official website for investors at mainzbiomed.com/investors/ for more information About Mainz Biomed NV Mainz Biomed develops market-ready molecular genetic diagnostic ...

Mainz Biomed NV (NASDAQ:MYNZ) ("Mainz Biomed" or the "Company"), a molecular genetics diagnostic company specializing in the early ...